PCM
ARNA

Penserra Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Penserra Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,791
Closed -$445K – 1517
2021
Q4 		$445K Sell
4,791
-1,400
-23% -$92.2K 0.01% 544
2021
Q3 		$368K Sell
6,191
-75,014
-92% -$4.43M 0.01% 550
2021
Q2 		$5.54M Sell
81,205
-21,504
-21% -$1.4M 0.1% 249
2021
Q1 		$7.13M Buy
102,709
+72,030
+235% +$5.54M 0.13% 183
2020
Q4 		$2.36M Sell
30,679
-1,805
-6% -$135K 0.06% 249
2020
Q3 		$2.43M Buy
32,484
+28,569
+730% +$1.9M 0.09% 203
2020
Q2 		$246K Buy
3,915
+435
+13% +$23.9K 0.01% 457
2020
Q1 		$146K Hold
3,480
– – 0.01% 494
2019
Q4 		$165K Buy
3,480
+876
+34% +$41.4K 0.01% 490
2019
Q3 		$119K Buy
+2,604
New +$146K 0.01% 519

Penserra Capital Management's ARNA Position: Q1 2022 in Review

Penserra Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,791 shares — an estimated $445K sold.

Penserra Capital Management first reported a position in ARNA in Q3 2019 and held it in 10 quarters. The position peaked at $7.13M in Q1 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Penserra Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Penserra Capital Management sold 4,791 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $445K.
  • Penserra Capital Management first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 10 quarters.
  • Penserra Capital Management's Arena Pharmaceuticals Inc position peaked at $7.13M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Penserra Capital Management's 13F filing for Q1 2022, filed 13 May 2022.